NCT01475305 - Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 20, 2011

Primary Completion Date

December 3, 2011

Study Completion Date

December 13, 2012

Conditions

RSV Infection

Interventions

DRUG

Placebo

Participants received single intravenous (IV) dose of placebo matched to MEDI-557 on Day 1 and were inoculated with respiratory syncytial virus (RSV-A) (Memphis-37 strain) as intranasal drops on Day 3.

DRUG

MEDI-557

Participants received single IV dose of 30 milligram per kilogram (mg/kg) MEDI-557 on Day 1 and were inoculated with RSV-A (Memphis-37 strain) as intranasal drops on Day 3.

Trial Locations (1)

E1 2AX

Research Site, London